Kadmos Capital

What Kadmos Capital does

Kadmos Capital is a London-based, FCA-registered venture capital firm (EuVECA, FRN 954103) headquartered in Notting Hill, investing at the seed to Series B stages in early-stage deep tech companies. The firm concentrates on three declared focus sectors — AI & Data, TechBio, and Sustainability — and articulates a thesis of backing "high-impact technologies at the intersection of science, technology and ambition." Its portfolio encompasses around 20+ companies, including Stability AI (generative AI, $1B valuation in 2022), Antiverse (AI-designed antibodies), OutSee (AI genomics), Scindo (AI enzyme discovery), Arda Biomaterials (plant-protein leather alternatives), Jua (AI weather/earth modeling), DEScycle (e-waste/critical metals recovery), Kelpi (sustainable materials), GlycanAge (biological age testing), Zora Ecosystems (forest regeneration/spatial data), Pangea Bio (neuroprotective therapeutics), Plurify (RNA platform), Moments Lab (agentic AI for video), CheMastery (AI chemistry), Pathway (post-transformer AI architecture), and iFAST Diagnostics (rapid antimicrobial susceptibility testing). Notable portfolio developments include multiple grant wins (EU Horizon, Innovate UK, Michael J. Fox Foundation), CB Insights AI 100 listings, Power Net Zero Future50 inclusion, and strategic corporate partnerships for portfolio companies (Mitsubishi with DEScycle, Novo Nordisk with Plurify, EA/Universal Music Group/WPP with Stability AI).

The firm is led by three named partners: Managing Partner Remy Kesrouani, General Partner John Gebeily, and Technology Partner Graham York. It operates with a small team of 1-10 employees. Co-investor activity in 2025-2026 spans lead and follow-on roles in rounds alongside Ahren Innovation Capital, Clay Capital, Oyster Bay Venture Capital, Soulmates Ventures, Oxx, Ananda Impact Ventures, Future Energy Ventures, 468 Capital, Green Generation Fund, and Just Climate (Generation Investment Management). The firm's geography spans Europe (UK primary), North America, and the Middle East (Saudi Arabia noted in operating geographies).

As a venture capital firm, Kadmos Capital's revenue model is management fees and carried interest on its fund(s); it does not publicly disclose fund size, AUM, or revenue. Distribution and GTM are network-based deal sourcing and reputation-driven LP fundraising typical of early-stage deep tech managers. No pricing, products, or customer-facing services are sold.

Name

Kadmos Capital

Legal name

Kadmos Capital Limited

Website

https://kadmoscapital.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Kadmos Capital is a London-based FCA-registered (EuVECA) venture capital firm investing at seed to Series B in early-stage deep tech companies across AI & Data, TechBio, and Sustainability, backing a portfolio of roughly 20+ technology companies led by three partners.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Financial Investment Activities (5239), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Technology & Software Growth Equity (FSANACAA)

Keywords

• Venture capital investments
• Deep tech funding
• Early stage capital
• Techbio investments
• Sustainability venture capital

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Core offering

Kadmos Capital is a London-based venture capital firm that provides early-stage equity capital to deep tech and impactful technology startups. The firm invests across AI & Data, TechBio, and Sustainability sectors, typically at seed and Series A stages, and supports portfolio companies with strategic guidance. It operates under an FCA EuVECA license enabling investments in qualifying SMEs.

Product overview

Kadmos Capital is a venture capital firm that invests in impactful technology companies across multiple sectors. As an investment firm, it does not offer a unified product platform or modular product architecture. The company deploys capital into portfolio companies developing technologies in areas including AI-driven drug discovery, biotechnology, sustainability, climate technology, and advanced data analytics.

Differentiator

Problem solved

Functional benefit

Products and services

• Early-stage venture capital investment Equity capital deployment into seed-stage deep tech startups across AI & Data, TechBio, and Sustainability sectors. Provided to founders of early-stage technology companies.
• Series A and growth-stage follow-on venture capital Equity participation in Series A and Series B funding rounds of portfolio companies, providing continuity of capital from seed through growth stages.
• Co-lead seed venture capital rounds Co-leading of seed funding rounds in deep tech startups, including the £4M Scindo seed round co-led with Clay Capital in September 2025.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Ahren Innovation Capital: UK-based early-stage deep tech venture capital firm investing in frontier science and technology companies. Directly comparable to Kadmos as it leads/co-leads deep tech seed rounds in AI, biotech, and climate tech with similar check sizes (e.g., led OutSee £2.5M seed).
• Soulmates Ventures: European deep tech VC firm focused on AI, biotech, and sustainability at seed to Series A stage. Directly comparable to Kadmos based on shared portfolio company Antiverse (Soulmates led Series A where Kadmos participated as existing investor).
• Clay Capital: UK-based deep tech VC investing in AI-driven biotech and sustainability startups at seed stage. Co-led Scindo's £4M seed round with Kadmos, making it a direct peer in early-stage deep tech deal-making.
• Oyster Bay Venture Capital: NYC-based early-stage VC investing in climate tech, food tech, and biotech. Directly comparable as it led Arda Biomaterials' $5.25M seed where Kadmos participated, and operates at similar check sizes and stage.
• Ananda Impact Ventures: European early-stage impact VC focusing on sustainability, climate tech, and health. Comparable to Kadmos through co-investment patterns in deep tech (e.g., Jua €10M Series A co-lead) and similar impact-investing thesis.
• Panacea Ventures: European deep tech VC firm investing in computational biology, AI, and healthcare. Participated in OutSee £2.5M seed alongside Kadmos, demonstrating similar sector focus and stage preferences in TechBio.
• Empirical Ventures: UK-based early-stage VC focused on transformative science and technology at seed stage. Co-invested with Kadmos in OutSee and shares a similar deep tech thesis spanning AI and life sciences.
• Clean Growth Fund: UK government-backed VC investing in cleantech and sustainability startups. Comparable to Kadmos's sustainability investments, including co-investment in Arda Biomaterials.

Broad incumbents

• Atomico: European venture capital firm investing broadly across technology sectors at multiple stages. While much larger and later-stage focused than Kadmos, both are London-based tech VCs operating with European deep tech exposure.
• Hoxton Ventures: London-based early-stage VC investing in European tech startups. Similar geographic focus and early-stage orientation to Kadmos, though typically invests in broader software/internet rather than exclusively deep tech.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/kadmoscapital

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments34 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kadmos Capital